1. Home
  2. SCVL vs CTNM Comparison

SCVL vs CTNM Comparison

Compare SCVL & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shoe Carnival Inc.

SCVL

Shoe Carnival Inc.

HOLD

Current Price

$16.89

Market Cap

551.6M

ML Signal

HOLD

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$12.19

Market Cap

507.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCVL
CTNM
Founded
1978
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
551.6M
507.0M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
SCVL
CTNM
Price
$16.89
$12.19
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
N/A
$19.80
AVG Volume (30 Days)
288.6K
232.9K
Earning Date
03-26-2026
03-05-2026
Dividend Yield
3.56%
N/A
EPS Growth
N/A
0.46
EPS
1.57
N/A
Revenue
$1,202,885,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.80
N/A
Revenue Growth
2.30
N/A
52 Week Low
$15.21
$3.35
52 Week High
$26.54
$16.33

Technical Indicators

Market Signals
Indicator
SCVL
CTNM
Relative Strength Index (RSI) 28.67 37.68
Support Level $16.79 $10.39
Resistance Level $18.37 $13.18
Average True Range (ATR) 0.79 1.17
MACD -0.34 -0.30
Stochastic Oscillator 1.56 4.29

Price Performance

Historical Comparison
SCVL
CTNM

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: